Kindeva Careers
Inventive, curious, and committed to results? We’re hiring.
Explore Job OpportunitiesNews
Whether making headlines for our work—or creating info you need now—you can find it here.
Kindeva Drug Delivery Announces the Appointment of David Stevens as Global CCO
Nutriband with Kindeva Drug Delivery select Aversa™ Fentanyl abuse deterrent formulation for commercial scale manufacturing process development
Kindeva and Meridian Combine: Create Leading Drug-Device Combination Product CDMO
Kindeva Drug Delivery and Meridian Medical Technologies To Combine
Kindeva Drug Delivery announces collaboration with the Temple University School of Pharmacy
Nutriband with Kindeva Drug Delivery demonstrate enhanced abuse-deterrent characteristics for Aversa™ Fentanyl
Kindeva Drug Delivery Acquisition of iPharma Labs Inc. Completed
Kindeva Drug Delivery Announces Collaboration with Synopsys
Kindeva and BOL Pharma Using Low Global Warming Potential (GWP) Propellant in Development of Inhaled Cannabinoid Products
Kindeva Drug Delivery to Acquire iPharma Labs Inc.
Virpax Pharmaceuticals Selects Kindeva Drug Delivery as Development Partner for Diclofenac pMDI Commercialization
Live-Attenuated VEEV Vaccine Delivered by iDNA Using Microneedles Is Immunogenic in Rabbits
Viatris Inc. Announces Receipt of the First FDA Approval for Generic Version of Symbicort® Inhalation Aerosol, Breyna™ (Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol), in Partnership with Kindeva
Kindeva Drug Delivery to Manufacture New, Greener Inhalers at UK Manufacturing Site to Help Cut Carbon Emissions
Kindeva Welcomes Mike Ratigan to the Leadership Team
IPAC-RS Welcomes Kindeva’s Mike Needham to the Board
Nutriband Inc. and Kindeva Drug Delivery sign feasibility agreement to develop AVERSA™ Fentanyl, an abuse deterrent fentanyl patch
Steve Fuechtmann Joins Kindeva Drug Delivery as CFO
Kindeva Drug Delivery commits to sustainable inhaler production with significant new manufacturing investment
Drug Delivery Veteran, Raj Khankari, joins Kindeva Drug Delivery
Accelerating sustainable healthcare product development.
The Medical Alley Association Welcomes Kindeva Drug Delivery CEO Aaron Mann to Board of Directors
Kindeva Drug Delivery Announces Collaboration with Monash University to Study Sustainable Propellants
Kindeva Drug Delivery Announces Knowledge Transfer Partnership with Loughborough University to Study Sustainable Propellants
Kindeva Appoints Greg Sargen to Board of Directors
Kindeva Drug Delivery and Cambridge Healthcare Innovations Limited to Collaborate on Development of Novel Dry-Powder Inhaler Product
Kindeva seals deal to expand operations at Charnwood Campus
Viatris Inc. and Kindeva Drug Delivery Announce FDA Tentative Approval of the First Abbreviated New Drug Application Generic Version of Symbicort® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol
Kindeva Appoints Shawn Cavanagh to Board of Directors
Kindeva and BOL Pharma Sign Agreement for Development of Inhaled Cannabinoid Products
Kindeva Drug Delivery Celebrates Breaking Ground for New Headquarters
Q&A with Kindeva Drug Delivery: Putting patients at the centre of drug development
Planning for Brexit : A case study on the strategic role CDMOs can play for their customers
Kindeva experts speak with ODD about future innovation in sustainable inhalation drug delivery
Kindeva scientists talk to BBC Witness History about the world's first modern asthma inhaler
Kindeva experts talk to PMPS about the lasting impact COVID-19 will have on drug delivery
Show, don't tell: how CDMO quality systems affect your product
Biotech's mirrored universe: predictive engineering and digital twinning
Addressing the challenges of vaccines and intradermal delivery
Kindeva: A historic CDMO, reborn
Kindeva talks to the Star Tribune about its launch as an independent company
Kindeva Drug Delivery launches as an independent company
Events
Whether leading, attending, or hosting, we stay busy and in the loop.
˅
International Conference on Microneedles
International Conference on Microneedles
Seattle, WA
May 15-17, 2023
The International Conference on Microneedles provides a unique international forum for academics and industry involved in the design, development, application and clinical translation of microneedle technology. The conference includes keynote presentations from leaders in the field interspersed with early career researcher presentations and opportunities for networking where researchers at all levels can interact.
Click here to register.
˅
American Association of Pharmaceutical Scientists – 2023 Summer Scientific Forum
˅
PODD: Partnerships in Drug Delivery
PODD: Partnerships in Drug Delivery
The Westin Copley Place, Boston
October 16-17, 2023
Pharma, biotech and the drug delivery industries gather annually at PODD to assess delivery needs, latest trends and information on deals and learn about a wide range of innovative drug delivery technologies that could improve the delivery of various types of drugs. This can include proteins, peptides, oligonucleotides, biologics, and small molecules and more. PODD provides business development opportunities through organized networking and a partnering tool for new, emerging and established collaborations.
Click here to register.
˅
DDL 2023 Drug Delivery to the Lungs
DDL 2023 Drug Delivery to the Lungs
Location: TBD
December 6-8, 2023
DDL attracts a wide variety of attendees, including scientists, academics, clinicians, regulators and industry experts. DDL offers the opportunity for lectures, posters and exhibitions to be closely located thereby enhancing interactions and networking opportunities for attendees, presenters and exhibitors. DDL is a not-for-profit conference and any surplus funds are provided as grants or awards, targeting research and training of the next generation of aerosol and drug delivery scientists.
Click here to register.